3 completed, 2 recruiting, 2 terminated, 1 active not recruiting. 9 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 3, Recruiting 2, Terminated 2, Active not recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
Follow Anaplastic Ependymoma: new trials by email Literature Review of Anaplastic Ependymoma trials Research Report on Anaplastic Ependymoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors LUTATHERA® (Lutetium Lu 177 dotatate) - High Grade Glioma, Meningioma | Phase 1 / Phase 2 | Recruiting | Nationwide Children's Hospital | 65 | 2022-11-21 | 2026-11-16 |
| A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years, SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 years, SurVaxM for patients with non-relapsed DIPG post radiation-therapy ages ≥1 and ≤21 years - Medulloblastoma, Glioblastoma Multiforme | Phase 1 | Active not recruiting | Children's Oncology Group | 35 | 2022-07-01 | 2026-06-02 |
| Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer Etoposide, Fludarabine Phosphate, Hematopoietic Cell Transplantation - Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2021-01-14 | 2024-10-26 | |
| LET Optimized IMPT in Treating Pediatric Patients With Ependymoma Linear Energy Transfer-Optimized Intensity Modulated Proton Therapy, Quality-of-Life Assessment, Questionnaire Administration - Anaplastic Ependymoma, Ependymoma | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 48 | 2019-04-01 | 2026-11-10 |
| SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors Gemcitabine, ribociclib, sonidegib - Anaplastic Astrocytoma, Anaplastic Ependymoma | Phase 1 | Completed | St. Jude Children's Research Hospital | 68 | 2018-03-05 | 2024-05-31 |
| Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma Laboratory Biomarker Analysis, Lapatinib, Lapatinib Ditosylate - Anaplastic Astrocytoma, Anaplastic Ependymoma | Phase 1 | Completed | National Cancer Institute (NCI) | 29 | 2016-11-07 | 2024-11-06 |
| Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine Heat Shock Protein Peptide Complex-96 (HSPPC-96), Tumor Resection, Radiation - Glioblastoma Multiforme, Astrocytoma, Grade III | Phase 1 | Terminated | Ann & Robert H Lurie Children's Hospital of Chicago | 10 | 2016-07-01 | 2025-02-18 |
| Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas AXL1717 - Glioblastoma, Gliosarcoma | Phase 1 / Phase 2 | Terminated | Rush University Medical Center | 10 | 2012-12-01 | 2023-05-22 |
| Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 therapeutic allogeneic lymphocytes, aldesleukin, laboratory biomarker analysis - Anaplastic Astrocytoma, Anaplastic Ependymoma | Phase 1 | Completed | City of Hope Medical Center | 6 | 2011-03-22 | 2026-10-19 |
Ependymoma (9) · Astrocytoma (6) · Glioblastoma (6) · Glioma (5) · Oligodendroglioma (5) · Brain Neoplasms (4) · Medulloblastoma (4) · Gliosarcoma (3) · Meningioma (3) · Neuroectodermal Tumors, Primitive (3) · Central Nervous System Neoplasms (2) · Choroid Plexus Carcinoma (2) · Diffuse Intrinsic Pontine Glioma (2) · Neoplasms, Germ Cell and Embryonal (2) · Rhabdoid Tumor (2)
Neoplasms by Histologic Type (9) · Neoplasms, Glandular and Epithelial (9) · Neoplasms, Nerve Tissue (9) · Neuroectodermal Tumors (9) · Neoplasms (8) · Neoplasms, Neuroepithelial (8) · Neoplasms, Germ Cell and Embryonal (7) · Brain Diseases (6) · Central Nervous System Diseases (6) · Neoplasms by Site (6) · Nervous System Diseases (6) · Nervous System Neoplasms (6) · Central Nervous System Neoplasms (4) · Glioma (4) · Meningeal Neoplasms (3)
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1) · Antilymphocyte Serum (1) · Etoposide (1) · Filgrastim (1) · Gemcitabine (1) · Granulocyte Colony-Stimulating Factor (1) · Hematopoietic Stem Cell Transplantation (1) · Interleukin-2 (1) · Interleukins (1) · Lapatinib (1) · Linear Energy Transfer (1) · Magnetic Resonance Spectroscopy (1) · Melphalan (1) · Mycophenolic Acid (1) · N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine (1)
M.D. Anderson Cancer Center (2) · Ann & Robert H Lurie Children's Hospital of Chicago (1) · Children's Oncology Group (1) · City of Hope Medical Center (1) · National Cancer Institute (NCI) (1) · Nationwide Children's Hospital (1) · Rush University Medical Center (1) · St. Jude Children's Research Hospital (1)
United States (8) · Canada (1)
Behnam Badie (1) · Clare Twist, MD (1) · David R Grosshans (1) · Giles W. Robinson, MD (1) · Kris M Mahadeo, MD (1) · Margot Lazow, MD (1) · Robert Aiken, MD (1) · Stewart Goldman, MD (1) · Timothy F Cloughesy (1)
P30CA016672 (1), U01CA137443 (1), U19CA021239 (1), UM1CA081457 (1), UM1CA137443 (1)